These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 22749945)

  • 1. Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
    Demirtas-Tatlidede A; Vahabzadeh-Hagh AM; Pascual-Leone A
    Neuropharmacology; 2013 Jan; 64():566-78. PubMed ID: 22749945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive brain stimulation in neurological diseases.
    Schulz R; Gerloff C; Hummel FC
    Neuropharmacology; 2013 Jan; 64():579-87. PubMed ID: 22687520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.
    Val-Laillet D; Aarts E; Weber B; Ferrari M; Quaresima V; Stoeckel LE; Alonso-Alonso M; Audette M; Malbert CH; Stice E
    Neuroimage Clin; 2015; 8():1-31. PubMed ID: 26110109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions.
    Sathappan AV; Luber BM; Lisanby SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():347-360. PubMed ID: 30312634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia.
    Hahn B; Gold JM; Buchanan RW
    Neuropharmacology; 2013 Jan; 64():185-90. PubMed ID: 22705396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
    Schmeichel BE; Zemlan FP; Berridge CW
    Neuropharmacology; 2013 Jan; 64(1):321-8. PubMed ID: 22796428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive enhancement as a treatment for drug addictions.
    Sofuoglu M; DeVito EE; Waters AJ; Carroll KM
    Neuropharmacology; 2013 Jan; 64(1):452-63. PubMed ID: 22735770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)-From insights into human memory to therapy of its dysfunction.
    Sparing R; Mottaghy FM
    Methods; 2008 Apr; 44(4):329-37. PubMed ID: 18374276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention.
    Callahan PM; Terry AV
    Handb Exp Pharmacol; 2015; 228():161-89. PubMed ID: 25977082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of noninvasive brain stimulation in childhood psychiatric disorders: new diagnostic and therapeutic opportunities and challenges].
    Rubio-Morell B; Rotenberg A; Hernández-Expósito S; Pascual-Leone Á
    Rev Neurol; 2011 Aug; 53(4):209-25. PubMed ID: 21780073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of non-invasive brain stimulation with direct currents (tDCS) in neuropsychiatric diseases.
    Kuo MF; Paulus W; Nitsche MA
    Neuroimage; 2014 Jan; 85 Pt 3():948-60. PubMed ID: 23747962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromodulation and Cognitive Control of Emotion.
    Amidfar M; Ko YH; Kim YK
    Adv Exp Med Biol; 2019; 1192():545-564. PubMed ID: 31705513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of transcranial magnetic stimulation in psychiatry and neurosciences research.
    Fitzgerald PB; Brown TL; Daskalakis ZJ
    Acta Psychiatr Scand; 2002 May; 105(5):324-40. PubMed ID: 11942939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.
    Silverman JL; Oliver CF; Karras MN; Gastrell PT; Crawley JN
    Neuropharmacology; 2013 Jan; 64(1):268-82. PubMed ID: 22801296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing thoughts for cognitive enhancement.
    Kantak KM; Wettstein JG
    Handb Exp Pharmacol; 2015; 228():451-9. PubMed ID: 25977093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.
    Maeda F; Pascual-Leone A
    Psychopharmacology (Berl); 2003 Aug; 168(4):359-76. PubMed ID: 12830365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating behavioral inhibition by tDCS combined with cognitive training.
    Ditye T; Jacobson L; Walsh V; Lavidor M
    Exp Brain Res; 2012 Jun; 219(3):363-8. PubMed ID: 22532165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
    Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
    Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does non-invasive brain stimulation improve cognition in major depressive disorder? A systematic review.
    Tortella G; Selingardi PM; Moreno ML; Veronezi BP; Brunoni AR
    CNS Neurol Disord Drug Targets; 2014; 13(10):1759-69. PubMed ID: 25470400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.